Healthwise Centre of Expertise and UMCG organise a symposium on expensive medicines

Healthwise Centre of Expertise of the University of Groningen and the University Medical Center Groningen will host a symposium relating to the theme ‘Expensive medicines’ on Wednesday, 31 May. Among others, Wouter Bos, Bart Benraad and Alfred Bein will present their view of drug prices on that occasion. Mr Bos is chairman of the VUmc board, Mr Benraad is a programme manager at the Association of Dutch Health Insurers (Zorgverzekeraars Nederland) and Mr Bein is the general director of Novartis Pharmaceutical Company.
Due to the growing knowledge in the field of health and disease control, the world of medicines is making major steps forward. An increasing amount of both new and improved drugs, offering prospects for patients with severe conditions, are put on the market. At the same time, expenditure on medicines in this country has significantly increased because certain groups of medicines come with hefty price tags. This means that the question from society ‘How do we keep medicines expenditure within the budget?’ is a highly topical issue.
Appropriate solution
At the symposium, a number of prominent speakers from the healthcare sector will draw a comprehensive picture of the issues which our society will be confronted with. Based on their specific skills and expertise, the speakers will furnish a number of solutions to encourage the debate. The impact of politics on the healthcare sector will also be discussed. The aim of the discussion is to provide a frame of reference for solving the issue of too costly medicines.
Interested in attending the symposium?
Those interested are very welcome at this spring symposium, which will be held in the red hall and the blue patio at UMCG from noon till 5 p.m. Please sign up via www.rug.nl/healthwise/events/symposia . The entrance fee is €75.00.
About Healthwise
Healthwise is one of eleven centres of expertise set up by the Faculty of Economics and Business of the University of Groningen. Healthwise connects scientific knowledge with questions from practice by conducting multi-disciplinary research within the healthcare sector. Experienced researchers and students provide research which is customized to the needs of various organisations and based on both social and business questions. Healthwise's applied research ties in with the latest developments in society and focusses on translating fundamental knowledge into healthcare practice, both now and in the future. By sharing knowledge, the researchers and professionals linked to Healthwise want to make a contribution to guaranteeing the future of the healthcare sector.
More information
Contact: Isabella Bazuin
NB: Please note that this event is in Dutch
________________________________________________
> More news from the Faculty of Economics and Business
> FEB experts in the media


Last modified: | 29 February 2024 10.02 a.m. |
More news
-
08 May 2025
6 million euro for large-scale northern project on sustainable healthcare: Care2Change
Care2Change. A large consortium with just about all northern hospitals, local governments, knowledge institutions such as the University of Groningen and the Hanze university of Applied Sciences, and a number of healthcare companies, will cooperate...
-
01 April 2025
UGBS Executive MBA best-rated MBA | Dutch Master's Guide 2025
According to the independent Keuzegids Masters 2025, the Executive MBA of the University of Groningen Business School is the best rated MBA in the Netherlands (both part-time and full-time programmes).
-
01 April 2025
Executive Master of M&A and Valuation accredited as joint degree with Vrije Universiteit Amsterdam
Starting 1 September, participants enrolled in the programme will receive a master's degree from both the University of Groningen and Vrije Universiteit Amsterdam upon successful completion.